Trials / Completed
CompletedNCT02206711
Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.
Pharmacokinetics and Metabolism of [14C] BMS-955176 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- ViiV Healthcare · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the pharmacokinetics (PK), metabolism, routes and extent of elimination, safety and tolerability of a single oral dose of \[14C\] BMS-955176 in healthy male subjects. There is no formal research hypothesis to be statistically tested for this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-955176 | Single dose of drug on Day 1 |
Timeline
- Start date
- 2014-08-08
- Primary completion
- 2014-09-09
- Completion
- 2014-09-09
- First posted
- 2014-08-01
- Last updated
- 2018-04-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02206711. Inclusion in this directory is not an endorsement.